2024-06-162024-06-162015https://doi.org/10.60810/openumwelt-865https://openumwelt.de/handle/123456789/8405The potential of Human Biomonitoring (HBM) in exposure characterisation and risk assessment is wellestablished in the scientific HBM community and regulatory arena by many publications. The EuropeanEnvironment and Health Strategy as well as the Environment and Health Action Plan 2004-2010 of theEuropean Commission recognised the value of HBM and the relevance and importance of coordination ofHBM programmes in Europe. Based on existing and planned HBM projects and programmes of work andcapabilities in Europe the Seventh Framework Programme (FP 7) funded COPHES (COnsortium to PerformHuman Biomonitoring on a European Scale) to advance and improve comparability of HBM data<BR>across Europe. The pilot study protocol was tested in 17 European countries in the DEMOCOPHES feasibilitystudy (DEMOnstration of a study to COordinate and Perform Human biomonitoring on a EuropeanScale) cofunded (50%) under the LIFEþ programme of the European Commission. The potential ofHBM in supporting and evaluating policy making (including e.g. REACH) and in awareness raising onenvironmental health, should significantly advance the process towards a fully operational, continuous,sustainable and scientifically based EU HBM programme. From a number of stakeholder activities duringthe past 10 years and the national engagement, a framework for sustainable HBM structure in Europe isrecommended involving national institutions within environment, health and food as well as Europeaninstitutions such as ECHA, EEA, and EFSA. An economic frame with shared cost implications for nationaland European institutions is suggested benefitting from the capacity building set up by COPHES/DEMOCOPHES.© 2014 Elsevier Inc. All rights reserved.enghttp://rightsstatements.org/vocab/InC/1.0/PolitikWissenschaftlicher Artikel